Expansion Nears Completion in Switzerland

CSL Behring validates new production capacity in Bern.

Graphic CSL Full Year Results 2020

CSL Delivers Net Profit of Over $2.1 Billion

CSL Limited (ASX:CSL; USOTC:CSLLY) today announced a reported net profit after tax of $2,103 million (1) for the 12 months en…

19 Aug 2020 Bern Location
female scientist injects solution into a test tube

New partner for BaseLaunch

CSL Behring to become latest partner in BaseLaunch Phase II

06 Aug 2020 Company
scientist turns in the lab with her ponytail flying behind her

Careful Steps Into a New Normal

One of CSL Behring's newest innovation centers in Bern, Switzerland, springs back to full life, with COVID-19 precautions in …

15 Jul 2020 Bern Location

Bern's contribution against COVID-19

CSL Behring in Bern manufactures the hyperimmune for the pivotal Phase III clinical trial.

10 Jul 2020 Bern Location

In Fight Against COVID-19

CSL Behring now evaluating 5 approaches to preventing and treating COVID-19.

09 Jul 2020 Bern Location

Welcome back Stadium Wankdorf

CSL Behring is proud stadium partner of BSC YB!

01 Jul 2020 Bern Location

Get a Look Inside Protinus

CSL Behring in Bern has made major progress on a large expansion project Protinus at its manufacturing facility.

30 Jun 2020 Bern Location
R&D employees at work

CSL Behring to Acquire Biotech Company Vitaeris

Builds on CSL Behring’s promise and commitment to the transplant community

08 Jun 2020 Company